Check(ed)-Out Hearts: Myocarditis in the Immunotherapy Era

Monday, April 13, 2026

12:05 PM - 12:15 PM PT

Location: Cascade Ballroom II - 2nd Floor

CE: 0.25 CME Credit

Speaker(s)

Mohamed Hagahmed, MD, MPH (he/him/his)

Clinical Assistant Professor, Department of Emergency Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Mohamed Hagahmed, MD, MPH: No financial relationships to disclose

Immune checkpoint inhibitors (ICIs) are revolutionizing cancer care—but they can also ignite rare, potentially fatal immune-mediated toxicities. Among the most dangerous is myocarditis, a stealthy cardiac complication with high mortality if missed. In this fast-paced, high-yield session, Dr. Mohamed Hagahmed unpacks the clinical red flags of ICI-related myocarditis, explores its pathophysiology, and shares real-world strategies to improve early recognition in acute and emergency care settings.

Attendees will learn how to distinguish myocarditis from more common presentations, identify subtle ECG and troponin clues, and understand when to escalate for advanced cardiac or oncologic consultation. Whether you work in the ED, ICU, or general medicine, this talk will equip you to detect the dangerous intersection of immunotherapy and cardiac injury—before it's too late.

Learning Objectives:

After this session, the learner will be able to identify key clinical signs and diagnostic clues of myocarditis in patients receiving immune checkpoint inhibitors.
After this session, the learner will be able to outline an evidence-informed approach to the initial evaluation and management of suspected immune checkpoint inhibitor–related myocarditis.
After this session, the learner will be able to collaborate effectively with oncology and cardiology teams to ensure timely diagnosis and treatment of immune-related myocarditis.